Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Lipegfilgrastim, sold under the brand name Lonquex, is a medication used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adults. It is given by injection under the skin in the abdomen, upper arm or thigh.
Read the full article on WikipediaChemotherapy-induced neutropenia Clinical criteria: Patient must be receiving chemotherapy with the intention of achieving a cure or a substantial remission, AND Patient must be at greater than 20% risk of developing febrile neutropenia; OR Patient must be at substantial risk (greater than 20%) of prolonged severe neutropenia for more than or equal to seven days.
“32–62 hours”
Working under the parallel aged-care framework? Aged-care equivalent →